CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Feb. 25, 2017	Feb. 27, 2016	Feb. 28, 2015
Operating activities:
Net (loss) income	$ (18,208)	$ 21,796	$ 79,742
Net loss from discontinued operations, net of tax	(53,364)	(7,126)	(9,357)
Net income from continuing operations	35,156	28,922	89,099
Adjustments to reconcile net income to net cash provided by operating activities:
Impairment charges and store closing costs	13,312	43,637	2,030
Depreciation and amortization	49,376	42,190	36,491
Deferred income taxes	8,223	(570)	22,423
Loss on disposals of property and equipment	703	139	338
Share-based compensation	9,945	10,567	7,951
Excess tax benefits from share-based compensation	(472)	(316)	(2,206)
Changes in operating assets and liabilities:
Accounts receivable, net	(3,988)	(255)	(143)
Merchandise inventories, net	16,820	(25,974)	(38,776)
Other assets	1,700	(8,339)	7,076
Accounts payable	15,576	26,888	14,828
Employee compensation	(3,515)	(323)	(5,291)
Income taxes receivable/payable	25,523	(15,629)	(16,469)
Other liabilities and accrued expenses	(2,475)	2,906	(386)
Deferred credits from landlords	1,630	3,345	657
Net cash provided by operating activities - continuing operations	167,514	107,188	117,622
Net cash used in operating activities - discontinued operations	(2,975)	(7,800)	(15,820)
Net cash provided by operating activities	164,539	99,388	101,802
Investing activities:
Capital expenditures for property and equipment	(74,784)	(62,144)	(85,415)
Payments for sale of discontinued operations	(8,317)	0	0
Proceeds from disposals of property and equipment	596	52	38
Cash paid for investments	0	0	(2,177)
Net cash used in investing activities - continuing operations	(82,505)	(62,092)	(87,554)
Net cash used in investing activities - discontinued operations	(1,659)	(12,259)	(13,593)
Net cash used in investing activities	(84,164)	(74,351)	(101,147)
Financing activities:
Borrowings on revolving credit facility	47,000	30,000	0
Repayments on revolving credit facility	(47,000)	(30,000)	0
Dividends paid to shareholders	(16,749)	(16,407)	(15,417)
Proceeds from issuance of common stock	39	1,976	6,609
Excess tax benefits from share-based compensation	472	316	2,206
Purchases of treasury stock	(52,776)	(79,880)	(68,053)
Net cash used in financing activities - continuing operations	(69,014)	(93,995)	(74,655)
Net cash used in financing activities - discontinued operations	0	(1,116)	(5,510)
Net cash used in financing activities	(69,014)	(95,111)	(80,165)
Net (decrease) increase in cash and cash equivalents	11,361	(70,074)	(79,510)
Cash and cash equivalents at beginning of year	79,495	149,569	229,079
Cash and cash equivalents at end of year	90,856	79,495	149,569
Supplemental disclosure of noncash operating and investing activities:
Capital expenditures incurred but not yet paid	$ 3,111	$ 5,700	$ 13,532